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Background: There are few Australian studies showing how research evidence is used to inform the development
of public health policy. International research has shown that compensation for injury rehabilitation can have
negative impacts on health outcomes. This study examined transport injury compensation policy in the Australian
state of Victoria to: determine type and purpose of reference to information sources; and to identify the extent of
reference to academic research evidence in transport related injury rehabilitation compensation policy.
Methods: Quantitative content analysis of injury rehabilitation compensation policies (N = 128) from the Victorian
state government transport accident compensation authority.
Results: The most commonly referenced types of information were Internal Policy (median = 6 references per
policy), Clinical/Medical (2.5), and Internal Legislation (1). Academic Research Evidence was the least often
referenced source of information. The main purpose of reference to information was to support injury treatment
and rehabilitation compensation claims decision-making.
Conclusions: Transport injury compensation policy development is complex; with multiple sources of information
cited including legislation, internal policy, external policy and clinical/medical evidence. There is limited use of
academic research evidence in Victorian state government injury treatment and rehabilitation compensation
policies. Decisions regarding compensation for injury treatment and rehabilitation services could benefit from
greater use of academic research evidence. This study is one of the first to examine the use of research evidence in
existing Australian public health policy decision-making using rigorous quantitative methods. It provides a practical
example of how use of research evidence in public health policy can be objectively measured.Background
Increasing use of research within public health policy
decision-making processes is expected to result in im-
proved public health outcomes [1,2]. Whilst the field of re-
search translation is rapidly developing, to date most of
the research examining use of research evidence in public
health agencies has been undertaken in the United States
and the United Kingdom. At present there are a limited
number of studies that have quantified what and how dif-
ferent types of information, including research evidence,
are used in Australian policy environments [3-5]. Studies
that have been undertaken in Australian public health pol-
icy environments have identified a need to build greater* Correspondence: pauline.zardo@gmail.com
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article, unless otherwise stated.capacity for use of research [6-8]. It is argued that context-
specific research is needed to inform the design and im-
plementation of interventions aimed at increasing capacity
for the use of research [9-11]. Measures of use of research
evidence are also critical to assessing the effectiveness of
such interventions [12].
Compensable injury is increasingly recognised as a
significant public health issue and policy challenge. Ap-
proaches to funding or supporting the costs of injury
treatment and rehabilitation and loss of income due to
injury vary significantly across countries and jurisdictions
[13,14]. Countries such as Canada, New Zealand and
Australia have ‘no fault’ injury compensation schemes
(Personal Injury Education [15]). The health systems in
these countries operate quite differently to those that pro-
vide comprehensive health treatment and services sup-
port, such as the National Health Service in the United
Kingdom; where costs relating to injury treatment andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ily covered by the one funding body [14,16,17]. The 2013
Commonwealth Fund Report showed that in Australia
‘out-of-pocket’ health care costs per capita are more than
double that in the United Kingdom [16].
Public compensation schemes in Australia provide com-
pensation for the financial and non-financial costs of injury
treatment and rehabilitation, including pain and suffering,
to people who have been injured in an accident. Compensa-
tion is accessed through both compensation claims and
common law processes (Personal Injury Education [15]).
Australia’s ‘no fault’ public compensation schemes operate
alongside Australia’s universal public healthcare (Medicare)
scheme and private health insurance, which is optional in
Australia [13]. Public compensation policies may overlap
with Medicare policies, but also provide compensation for
treatment and services not covered by Medicare or private
health insurance. A recent study of injured persons under-
taken in the Australian state of Victoria showed that
52.5% of the 118 participants accessed the state’s no-fault
public compensation scheme to fund their health care
costs, 40% were funded via Medicare and 16% via private
health insurance [13].
Public compensation schemes develop policies to guide
decisions regarding claims for financial compensation for
costs related to injury treatment and rehabilitation. Injured
persons, clinicians and compensation claims’ decision-
makers (claims decision-makers) can utilise compensation
policies to determine which injury treatments and rehabili-
tation services injured persons may be eligible to receive
compensation for. It is now recognised that policy regard-
ing the provision of healthcare services to injured people
should be informed by research evidence. For example, the
Institute for Work and Health in Canada exists to support
evidence-informed policy and practice regarding workplace
injury and illness prevention and compensation through
the production of research, research translation activ-
ity and the development of evidence-informed prod-
ucts [18]. In Australia, government healthcare policies,
such as those under the Medicare Benefits Schedule
which defines the healthcare services available under
Australia’s universal Medicare scheme, are now re-
quired to be based on research evidence and reviewed
within specified timeframes [19].
Examination of the health outcomes for people receiving
compensation for injury rehabilitation is a growing area of
focus for both researchers and governments. It has been
shown that individuals receiving injury treatment and re-
habilitation compensation can have poorer health outcomes
compared to those who have not received compensation
for the same types of injury, including experiences of
chronic pain, low back pain, general function etc. [20-23].
Another study found that access to compensation had a
protective effect on mortality [24]. These studies coverinjury compensation schemes from a range of countries
and regions, including the Australian state of Victoria. Two
of these studies found that the health outcomes for injured
participants receiving compensation remained evident after
controlling for the effect of confounding factors such as
age, injury severity and injury status [20,24].
Research has shown that a range of complex factors affect
the health outcomes of injured persons including: nature
and severity of injury; psychosocial factors; employment
and/or return to work status; management and education
of treatment and rehabilitation; as well as compensation ac-
cess and experience of compensation processes [23-25].
Other research has shown that macro changes in policy
such as legislative amendment can have substantial positive
impacts on the health outcomes of injured persons [26,27].
Considering the international push toward evidence-
informed policy and practice as a means for achieving
improved public health outcomes [28-30]; this research
highlights a need to better understand how public com-
pensation policy might support the achievement of im-
proved outcomes for injured persons [23,24].
In Australia, all states and territories have a transport ac-
cident compensation system. The estimated economic cost
of transport related injury in Australia is $18 billion per
year [31,32]. In the state of Victoria approximately 16,000
persons per annum claim compensation from the state
transport compensation authority, the Transport Accident
Commission (TAC). In 2010/11 the TAC spent $937 mil-
lion on injury rehabilitation compensation [33]. As such,
the TAC plays a critical public health role in Victoria. The
types of health care services the TAC funds include: ambu-
lance services, hospital services, medical and pharmacy ser-
vices, and physiotherapy and other injury rehabilitation
therapy and nursing services and individuals with severe in-
jury can receive life-time care [13,34]. Compensation claims
for injury treatment and rehabilitation services must meet
the eligibility requirements of TAC policies to be approved
and paid by the TAC.
Considering the substantial costs of injury compensa-
tion; the impact that both policy and compensation can
have on health outcomes; and the increasing recognition
that public health policies should be evidence-informed
where relevant and feasible; there is a pressing need to
examine the information that is being used to inform in-
jury treatment and rehabilitation compensation policy de-
velopment and decision-making. Understanding use of
information in compensation policy development and
decision-making provides an opportunity to identify how
academic research evidence might be used to support fu-
ture compensation policy development and decision-
making and contribute to improved health outcomes for
injured persons receiving compensation.
The objectives of this study were to: (1) examine the
types of information used in Victorian transport injury
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determine the purpose of reference to information in
these policies; and (3) determine the level of reference to
academic research evidence in these policies. This study
forms part of a larger study that has also examined the
use of information, including research evidence, in injury
prevention and rehabilitation compensation policy and
program development through self-reported measures.
Methods
A quantitative content analysis was undertaken on all
TAC injury rehabilitation compensation policy docu-
ments existing as at 30 December 2010 (N = 128). TAC
policies are designed to outline criteria regarding eligi-
bility for financial compensation for treatment and re-
habilitation for persons injured as a result of a transport
accident in Victoria. A very broad range of treatment
and non-treatment services are covered by the TAC for
those who can demonstrate eligibility, ranging from
acupuncture and massage to complex surgical treat-
ments and nursing services. See Additional file 1.
Quantitative content analysis seeks to count the occur-
rence and frequency of specific units of observation, such
as words, sentences or phrases, in a unit of analysis, such
as policies, newspapers, advertisements and other text
based documents [35,36].
Document selection
TAC injury rehabilitation compensation policy docu-
ments formed the unit of analysis. A single copy of each
policy was downloaded and saved from the TAC website
as at 30 December 2010 [37]. All policy documents col-
lected were printed and coded by hand. Each hyper-link
within the policies was checked to ensure its information
type and purpose was recorded accurately.
Categorisation and coding
In content analysis the decision about what to code is
driven by the research questions; ‘content analysis is an
approach to the analysis of documents and texts that seeks
to quantify content in terms of pre-determined categories
and in a systematic and replicable manner’ [35]. Based on
the research questions and initial coding and review of the
first 40 policies collected, the following categories of inter-
est were established: ‘type of information’, ‘purpose of refer-
ence to information’ and ‘type of policy’.
Words, sentences and phrases were defined as the unit
of observation. Codes were applied to explicit references
to words that described ‘type of information’, ‘purpose of
reference to information’ and ‘type of policy’. Explicit ref-
erence was defined as stated, not implied [36]. Codes were
expanded and changed as a result of the initial coding
process to ensure codes were ‘exhaustive, exclusive and
enlightening’ [36].Coding and counting process
For each of the 128 policies, the title of the policy, and
the existence (yes/no) and frequency of each code were
recorded.
 Coding for Type of Policy: First, each policy was
coded as either ‘treatment’ or ‘non-treatment’.
Treatment was defined as any type of treatment,
medicine or surgery applied to an individual to
physically or psychologically treat the injury.
Non-treatment was defined as provision of services
or equipment, not directly related to physical or
psychological treatment.
 Coding for Type of Information: Next, words,
sentences and phrases referring to a ‘type of
information’ were coded to describe the type of
information referenced. Eight types of information
were identified:
 Academic/Scientific Research Evidence:
references to published, peer reviewed academic
or scientific research evidence or actual citations
of published, peer reviewed academic or scientific
research evidence.
 Internal Legislation: references to the Transport
Accident Act 1986, or references to specific
sections of the Act.
 External Legislation: references to acts or
regulations other than the Transport Accident
Act 1986.
 Internal Policy: references to TAC policies.
 External Policy: references to policies from
government agencies (excluding the TAC) and
references to policies from professional
organisations.
 Clinical/Medical Evidence: references to medical
certificates, medical advice, any reference to
evidence or information justifying the need for
treatment or non-treatment services provided by
any medical/clinical practitioner.
 Costs Evidence: references to receipts and other
physical evidence of money spent on treatments
or non-treatment services.
 Other Evidence: references to evidence or
information that were not clearly defined, for
example ‘objective evidence’.
 Coding for Information Purpose: Finally, each ‘type
of information’ code was then coded for information
purpose. That is, each reference to information was
identified as either ‘supporting policy development’
or ‘supporting claims decision-making’. The code
‘supporting policy development’ meant the purpose
for reference to information was to validate the need
for the policy. In contrast, the code ‘supporting
claims decision-making’ meant the purpose for
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payment decisions made by TAC claim managers.
Words and sentences surrounding coded references
to information that described the purpose were used
to identify ‘information purpose’.
During the initial coding process, it became evident that
the policy document structure was largely consistent. Pol-
icies included sections entitled ‘Policy’ and ‘Guidelines’.
Codes in the ‘Policy’ section were almost always coded as
‘supporting policy’ while codes in the ‘Guidelines’ section
were almost always coded as ‘supporting claims decision-
making’. To ensure consistency of coding, the primary
coder (lead author) determined that all references to infor-
mation that came under the heading ‘Policy’ and/or prior
to the heading ‘Guidelines’ would be coded as ‘supporting
policy’ and that references to information under the head-
ing ‘Guidelines’ would be coded as ‘supporting claims
decision-making’. Where these headings were absent, the
words surrounding a reference to information were used
to identify and code ‘information purpose’.
Inter-rater analysis
An inter-rater analysis was undertaken to test the content
analysis method. To determine the number of policies that
would need to be inter-rated to detect more than a 20%
difference in the coding and counting for each variable be-
tween two raters, a power analysis with 80% statistical
power at the 5% significance level was performed. This
showed 39 or more policies needed to be inter-rated. A
second rater independently coded a random sample of 45
policies following the coding system developed by Rater 1
(Lead author).
The difference in coding for type of information and
information purpose between Rater 1 and Rater 2 was
tested using independent samples t-tests for frequencies
and the Mann–Whitney U-Test for categories, set at the
0.05 significance level. There were no significant differ-
ences between Rater 1 and Rater 2 for all frequencies
and categories, with the exception of the costs category,
which was excluded from further analyses.
Data analysis
Firstly, descriptive analyses were performed to determine
the number of references to information per policy and
per category of information. Frequency tables and histo-
grams for all counts of ‘type of information’, ‘information
purpose’ and ‘type of policy’ were used to analyse frequen-
cies. Cross-tabs were used to analyse categories of ‘type of
information’, ‘information purpose’ and ‘type of policy’.
Secondly, a comparison of the type of information re-
ferred to in treatment and non-treatment policies was
conducted. As the data were positively skewed, the Mann
Whitney U Test, set at the 0.05 significance level, was usedto test whether there was a statistically significant difference
in the median number of references to a type of informa-
tion in treatment compared to non-treatment policy.
Finally, a comparison of references to a type of informa-
tion that was identified as ‘supporting policy development’
or ‘supporting claims decision-making’ was conducted. As
the data were positively skewed, and the samples related,
the Related Samples Wilcoxon Signed Rank Test, set at
the 0.05 significance level, was used to test whether there
was a statistically significant difference in the median
number of references to a type of information in these two
categories.
All analyses were performed using Statistical Package
for the Social Sciences version 19.0.
Results
Internal Policy, Clinical/Medical Evidence, Internal Legis-
lation and Other Evidence were the types of information
most commonly referenced.
There were 50 references to academic research evi-
dence in 30 policies (23.4%). Academic Research Evi-
dence was the type of information least commonly
referenced (Table 1).
There were significantly more references to informa-
tion supporting claims decision- making compared to
references to information supporting policy development
(p = 0.000).
There were significantly more references to Internal
Policy, Clinical/Medical Evidence and Other Evidence
supporting claims decision-making compared to refer-
ences to information supporting policy development.
Internal Legislation and Internal Policy were the types
of information most often referenced to support policy
development (Table 2).
There were significantly more references to Academic
Research Evidence, Clinical/Medical Evidence, External
Legislation and Internal Legislation in treatment com-
pared to non-treatment policies (Table 3).
Discussion
Types of information referenced
Findings showed that Internal Policy and Internal Legisla-
tion are heavily relied upon by TAC policy decision-makers
when developing transport accident injury rehabilitation
compensation policy. It is not surprising that most policies
(95.3%) referred to Internal Legislation, as the organisa-
tional policies that the TAC develops must comply with the
relevant legislation. However, it is interesting that almost
all the policies (96.9%) referenced other internal policies,
meaning that essentially the organisation was referencing
their own prior policy decisions as justification for further
policy decisions. Internal Policy was referenced in almost
all policies and referenced more frequently than any other
type of information. Clinical/Medical Evidence was the
Table 1 Total references to information in injury treatment and rehabilitation compensation policy
Information type Frequency (% total) of
reference to information
N (%) policies that
reference information
Median (range) of reference
to information per policy
Internal policy 1133 (47.5) 124 (96.9) 6 (0–36)
Clinical/Medical evidence 519 (21.8) 108 (84.4) 2.5 (0–28)
Internal legislation 203 (8.5) 122 (95.3) 1 (0–11)
Other evidence 175 (7.3) 88 (68.7) 1 (0–13)
External policy 245 (10.3) 63 (49.2) 0 (0–24)
External legislation 58 (2.4) 22 (17.2) 0 (0–16)
Academic/Scientific research 50 (2.1) 30 (23.4) 0 (0–7)
Total 2383 (100.0) 128 (100.0) 15.5 (0–67)
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more than twice as frequently as Internal Legislation and
Other Evidence. Clinical/Medical Evidence was often
required by the TAC to verify an individual’s eligibility to
claim compensation for a given treatment. To assess clin-
ical/medical evidence provided by medical practitioners,
the TAC has developed a Clinical Justification Framework
to guide claims managers in decision-making regarding
compensation for particular treatment and services. There
is also a Clinical Panel comprised of clinical practitioners
that advise the TAC on compensation policy development
and implementation.
The extent to which Clinical/Medical Evidence, Internal
and External Legislation were referenced within treatment
policies suggested that development of treatment policies
is complex. To develop treatment compensation policies,
government policy workers must refer to and comply with
the requirements of a raft of other legislation and regula-
tions within the public health system. The complexities of
policy development at the health systems level has not
been well addressed in the evidence-informed policy lit-
erature to date [5,8,9,38-40].Purpose of reference to information
The primary purpose of reference to information was to
inform decision-making regarding eligibility for compen-
sation for treatment and non-treatment services claimed
by injured persons. References to information to support
claims decision-making were almost three times as fre-
quent as references to information to support policy de-
velopment. This indicates that in this context, information
is most often used to inform the implementation stage of
the policy process [4,5,41]. Clinical/Medical Evidence as
well as Internal Policy was used to inform decision-
making at this stage, demonstrating that decision-making
in public health is inter-dependent. In this context deci-
sions about compensation by claims decision-makers is
dependent on the information and evidence provided to
them by clinical practitioners.Use of academic research evidence
Whilst public health policy development is informed by
a range of information types, as well as ideology, politics
and community values; internationally there is growing
interest in ensuring that wherever possible or relevant,
health policy development is informed and/or supported
by research evidence [7,28,30,42,43]. In this study it was
expected that reference to academic research evidence
would be more frequent in treatment-focused policies
compared to non-treatment policies. This is because it
would be reasonable to expect that policies regarding
compensation for transport costs for example, would
not need to be informed by research evidence. Whereas
specific clinical treatments were expected to be more
likely to have available published evidence of effective-
ness. Whilst the compensation policies analysed were di-
verse, categorisation of policies into treatment and non-
treatment groups allowed us to compare research use
across these two broad types of policies.
Of the 65 treatment policies, 41 (63%) made no refer-
ence to Academic Research Evidence. There was also no
reference to Academic Research Evidence in 75% of the
policies that referenced information to support compensa-
tion decision-making. Access to appropriate treatment is
critical to effective and efficient recovery from injury. The
importance of evidence-informed treatment practice is
recognised at the national level in Australian public health
policy. The treatment compensation policies existing
under the Medicare Benefits Schedule are required to be
evidence-based and are subject to regular review to ensure
they remain effective and efficient over time, and take ac-
count of new evidence [19].
In the thirty policies that referenced academic research,
the most common reference was a ‘recent peer reviewed
journal article’; this was a generic statement within the
policies and not a reference to specific articles or studies.
Only six of the 30 policies that referred to academic re-
search cited published articles or specific studies. This
demonstrates that the main quality requirement for aca-
demic research evidence used to inform decision-making
Table 2 References to Information supporting policy development and claims decision-making
Information type Supporting policy development Supporting claims decision-making
Frequency (% total)
of reference to
information
N (% total) policies that
reference information
Median (range)
references per policy
Frequency (% total)
of reference to
information
N (% total) policies
that reference
information
Median (range)
references per policy
P Value
Internal policy 309 (51.5) 91 (72.8) 1 (0–27) 823 (46.2) 112 (93.3) 4.5 (0–35) p = <0.001
Clinical/Medical evidence 25 (4.2) 19 (15.2) 0 (0–3) 493 (27.6) 103 (85.8) 2 (0–28) p < =0.001
Internal legislation 150 (25.0) 115 (92.0) 1 (0–11) 55 (3.1) 32 (26.7) 0 (0–4) p < =0.001
Other evidence 25 (4.2) 14 (11.2) 0 (0–5) 150 (8.4) 83 (69.2) 1 (0–13) p < =0.001
External policy 53 (8.8) 19 (15.2) 0 (0–15) 192 (10.8) 55 (45.8) 0 (0–18) p < =0.001
External legislation 31 (5.2) 13 (10.4) 0 (0–16) 27 (1.5) 14 (11.7) 0 (0–5) p = 0.592
Academic/Scientific research 7 (1.2) 4 (3.2) 0 (0–3) 43 (2.4) 29 (24.2) 0 (0–5) p = <0.001
Total 600 (100.0) 125 (100.0) 3 (0–52) 1783 (100.0) 120 (100.0) 11 (0–65) p = < 0.001
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Table 3 References to information in non-treatment and treatment policies
Information type Non-treatment policies Treatment policies
Frequency (% total)
of reference to
information
N (% total) policies
that reference
information
Median (range)
references per policy
Frequency (% total)
of reference to
information
N (% total) policies
that reference
information
Median (range)
references per policy
P Value
Internal policy 579 (47.7) 59 (93.6) 6 (0–35) 554 (47.4) 65 (100.0) 6 (1–36) p = 0.785
Clinical/Medical evidence 214 (17.6) 49 (77.8) 2 (0–25) 305 (26.1) 59 (90.8) 3 (0–28) p = 0.029
Internal legislation 115 (9.5) 57 (90.5) 1 (0–11) 88 (7.5) 65 (100.0) 1 (1–7) p = 0.017
Other evidence 106 (8.7) 43 (68.2) 1 (0–13) 69 (5.9) 45 (69.2) 1 (0–3) p = 0.279
External policy 138 (11.4) 28 (44.4) 0 (0–24) 107 (9.1) 35 (53.8) 1 (0–17) p = 0.415
External legislation 52 (4.3) 18 (28.6) 0 (0–16) 6 (0.5) 4 (6.15) 0 (0–2) p = 0.001
Academic/Scientific research 10 (0.8) 6 (9.5) 0 (0–5) 40 (3.4) 24 (36.9) 0 (0–7) p = <0.001
Total 1214 (100.0) 63 (100.0) 13 (0–58) 1169 (100.0) 65 (100.0) 16 (3–67) p = 0.852
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erence in the policy text to ‘clinical trials’, ‘clinical research’,
or ‘high quality evidence’. Whilst it is critical that evidence
applied is peer reviewed and of publishable quality, how
recently the study was published is not an appropriate
quality indicator. The quality of treatment effectiveness
evidence is dependent on research methods. Hierarchies
of evidence place ‘gold standard’ research methods such
as systematic reviews and randomised controlled trials
(RCTs) at the top [44].
Whilst RCTs or systematic reviews are not always an
appropriate method for answering public health policy
questions [5,45,46], high quality evidence of treatment ef-
fectiveness is particularly relevant to injury rehabilitation
compensation policy. If particular treatments lack high
quality research evidence demonstrating their effectiveness,
governments can use this information to cease or decline
to provide compensation for that treatment. Conversely,
governments can use high quality research evidence to
identify and provide compensation for treatments that have
been shown to be effective. Ensuring that compensation
policies are informed by the best available research evi-
dence wherever possible is important for supporting both
claims and clinical decision-making, as it has been estab-
lished that clinicians may not always recommend or pro-
vide care that is aligned with current best practice
[29,42,47]. There is need for further research on clinical
decision-making regarding healthcare for persons receiving
compensation.
The limited reference to published academic research
suggests there is an opportunity to increase use of re-
search evidence in transport accident injury rehabilitation
compensation policy in Victoria. Whilst policy develop-
ment in this context may have been informed by research
evidence not referenced in the policy document, and there
would be instances where it is not possible or appropriate
to use research evidence, referencing the information used
to inform the development of the policy is necessary to
ensure decision-making is transparent. Increased use of
research evidence in compensation policy development
may be facilitated through the development of evidence
quality standards and the establishment of regular policy re-
view processes, such as that undertaken by the Australian
pharmaceutical and medical benefits schemes [19,48,49]
and informed by published literature on hierarchies of evi-
dence [44]. In the state of Victoria there are no externally
applied guidelines or standards that must be complied with
for the development of operational level government policy
such as TAC compensation policies.
The limited reference to academic research evidence
in the compensation policies analysed in this study may
also be attributed to well-known barriers to use of re-
search evidence in health policy decision-making. Policy
workers consistently cite lack of time and lack of skills inassessing research evidence as a barrier to use of evidence
[6,7,38,50]. Policy workers often find that research is not
relevant to their particular needs and the recommenda-
tions of research are not actionable in their context
[5,38,50]. Further, whilst there is much existing academic
research evidence on public health problems, significant
gaps remain [5,51,52].
Whilst policy is but one component of the compensa-
tion decision-making process, and that in this context
the TAC’s Clinical Justification Framework and Clinical
Panel also support claims decision-making; developing
systems and processes to ensure that wherever possible
compensation policies are informed by the best avail-
able evidence can support both policy development and
implementation. One of the key reasons for the devel-
opment of the Clinical Justification Framework was to
ensure that injured persons were receiving treatment
and management that would be ‘goal oriented, evidence
based and clinically justified’ [53]. Research evidence
can assist decision-making regarding whether a com-
pensation policy should be developed for a particular
treatment or service, and can also support decisions re-
garding the development of policy content.
Increased reference to and transparency regarding
the information types used to inform policy develop-
ment could enhance consistency and efficiency. Claims
decision-makers could refer to the evidence-informed
policies to make individual case decisions about
whether compensation can be paid for particular treat-
ments and services; rather than having to seek advice
from the Clinical Panel or searching research literature
to determine if the particular treatment or service met
the requirements of the Clinical Justification Frame-
work. It also supports clinicians and injured or ill per-
sons who are eligible for compensation to make
informed decisions regarding treatment and rehabilita-
tion services they seek to access.
There is a continued need for support in the applica-
tion of research evidence in health policy environments
[11,50,51]. Government organisations are subject to ex-
ternal pressures and competing interests that often require
them to develop a policy response to address public need
and concern, despite a lack of research evidence on the
issue at hand [5,41,54]. This study provides a practical ex-
ample of how use of research evidence can be assessed ob-
jectively (as opposed to self-report measures) in a public
health policy environment. This data also provides a base-
line from which change in use of research in this environ-
ment can be measured following the implementation of
research translation interventions. There remains a need
for the development of evidence-based context-specific in-
terventions and tools that can effectively increase and sup-
port use of research evidence in public health policy
environments [5,38,55,56].
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In the Victorian compensation policy development context
there is an opportunity to improve the capacity for use of
academic research evidence by policy decision-makers, po-
tentially through the development of evidence quality stan-
dards and regular policy review processes. Specifically,
government decision-making about what injury treatment
and non-treatment services will be compensated for could
be better informed by high quality research evidence. Inter-
ventions aimed at increasing the use of research evidence
in this context must target capacity for assessing the quality
of academic research evidence and increase access to and
awareness of academic research evidence relevant to injury
rehabilitation compensation policy.
Academic research evidence can provide an important
counter weight to other information types used to inform
injury rehabilitation compensation policy. However, it is
important for those seeking to influence use of research
evidence in compensation policy development to be cog-
nisant of the fact that policy development in this context
is complex and interdependent, and that academic re-
search will only ever be one of several inputs into the pol-
icy process. To be actionable by government, academic
research findings and recommendations must address the
system level, jurisdictional constraints that compensation
policy workers must work with in the development and
implementation of compensation rehabilitation policy.
Improving the quantity and quality of research evi-
dence used to inform policy development and claims
decision-making in this context has the potential to result
in improved compensation health outcomes. Evidence of
effectiveness can be used to guide injured persons receiv-
ing compensation toward treatments and services that can
improve their recovery and away from treatments and ser-
vices that show no evidence of effectiveness. Whilst policy
is just one component contributing to the health out-
comes experienced by those receiving compensation; it is
a foundation for injury rehabilitation compensation prac-
tice and decision-making that can influence the behaviour
of claims decision-makers, health care providers, lawyers
and others involved in the injury treatment and rehabilita-
tion compensation process.Additional file
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